| Home > In process > Intranasal blood-brain barrier bypass enables sequential mitochondria-targeted bioengineered nanolamellar system for ischemic stroke therapy. > Access to Fulltext |
| Restricted | |||||||
DZNE-2026-00080
|
|||||||
| version 1 |
| ||||||